Nurix Therapeutics Inc (NASDAQ:NRIX) traded at $12.47 at close of the session on Monday, April 29, made an upward move of 0.89% on its previous day’s price.
Looking at the stock we see that its previous close was $12.36. In terms of its 52-week price range, NRIX has a high of $18.12 and a low of $4.22. The company’s stock has lost about -15.17% over that past 30 days.
Nurix Therapeutics Inc has a market cap of $739.72 million. Estimates by analysts give the company expected earnings per share (EPS) of -$0.67, with the EPS growth for the year raised at -$2.91 for 2024 and -$3.17 for next year. These figures represent -9.80% and -8.90% growth in EPS for the two years respectively.
Analysts tracking the company’s growth have also given it a consensus growth in revenue estimated at $23.44 million, with a low of $13.5 million and a high of $32.5 million. According to analyst consensus estimates figures, the company’s yearly revenue forecast for 2024 is expected to hit $74.24 million, or -3.60% down from figures reported last year.
On the other hand, looking at the outlook for the NRIX stock, short term indicators assign the stock an average of 50% Buy, while medium term indicators assign it an average of 50% Buy. Long term indicators on average place the stock in the category of 100% Buy.
Looking further, we note the current price level is -14.35% off its SMA20 and -7.72% from its 50-day simple moving average. The RSI (14) is pointing at 41.65 while the volatility over the past week is 6.03% and jumps to 8.71% over the past one month. The beta value is 2.10, while the average true range (ATR) is currently pointing at 1.19.
Coming back to Nurix Therapeutics Inc (NASDAQ:NRIX), we note that the average 3-month trading volume was 1.02 million. Current shares outstanding are 59.32 million.
The insiders hold 7.90% of the company’s shares while institutions hold 69.68%. Investors should be excited about this stock as its upside potential is great, with current price pushing the stock 20.83% up in year-to-date price movement.
